Business Of Biotech

TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono

Mar 13, 2023
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
The Importance of Guest Editor Space in Bio Process Online
01:32 • 2min
3
Dietrich Stefan's Business of Biotech
03:06 • 2min
4
The Path to a Career in the Pharma Industry
04:49 • 2min
5
The Life and Times of Gary Friedlander
06:51 • 5min
6
The Power of Personal Connections in PR
11:29 • 5min
7
The One Common Currency of Biotech Is Data
16:04 • 2min
8
The Noise in the Oncology Industry
17:36 • 5min
9
The Importance of Small Wins
22:34 • 3min
10
The Origin Story of Blue Sphere
25:33 • 2min
11
UPMC Enterprises: A Private Company With a Private Investor
27:30 • 3min
12
The Uncomfortable Life After COVID
30:28 • 2min
13
The Importance of Investing in a Company
32:25 • 4min
14
The Monongahela in Pittsburgh
36:32 • 2min
15
Tc Express New Express: A New Drug Development Company
38:57 • 2min
16
The Importance of Having a Fully Automated Lab Space
41:08 • 3min
17
The Preclinical Pipeline Strategy for TCRT Cell Therapy
44:23 • 5min
18
Transplanting T Cells to Prevent Relapse
49:27 • 2min
19
TCX201: A Therapeutic Approach
51:56 • 6min
20
Blue Sphere's Strategy to Crack the Solid Tumor Nut
57:31 • 6min
21
The Importance of Preclinical Data in Oncology
01:03:29 • 6min